CRMD: CorMedix Inc.
Performance
CRMD -49.16%
Watchlist
Select an item
Summary
CRMD at a glance
CRMD returned -49.16% over the past year and +0.15% a year over five years. Its worst drop in that year was -58.92%, smaller than 13% of stocks on Redstone, and its Sharpe ratio of -0.77 beats 7% of stocks on Redstone. It pays no dividends.
Current Drawdown
-57.03%
Rolling Volatility
100.23%
Actions
Metrics
Risk Indicators
Alpha-62.52%
Beta1.38x
Sharpe-0.77
Sortino-0.90
Omega0.85
Calmar-0.83
Martin-1.31
Profile
About CRMD
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $426M
- Listed
- May 2010
- Employees
- 191
- Headquarters
- Parsippany, NJ
- Website
- cormedix.com
Comparisons